Outlook Therapeutics (OTLK) EBITDA Margin Growth (3y) (2018 - 2019)
Outlook Therapeutics (OTLK) EBITDA Margin Growth (3y) (2018 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -2,649.00 |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 179,421.00 |
| Jun 30, 2019 | 348,423.00 |
| Mar 31, 2019 | -90,495.00 |
| Dec 31, 2018 | 68,896.00 |
| Sep 30, 2018 | 190,201.00 |
| Jun 30, 2018 | -8,233.00 |
| Mar 31, 2018 | 194,425.00 |